Last reviewed · How we verify
Tacrolimus with steroids minimization
Tacrolimus with steroids minimization, marketed by Armando Torres Ramírez, is an immunosuppressive therapy with a key composition patent expiring in 2028. The drug's key strength lies in its mechanism of minimizing steroid use, potentially offering a differentiated treatment option for patients. The primary risk is the lack of reported revenue and key trial results, which may limit its market adoption and competitive positioning.
At a glance
| Generic name | Tacrolimus with steroids minimization |
|---|---|
| Also known as | Simulect; Dacortin; Prograf/Advagraf; Cellcept/Myfortic. |
| Sponsor | Armando Torres Ramírez |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure (PHASE3)
- Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation (PHASE4)
- KidneyCare Immuno-optimization in Renal Allografts (KIRA) (NA)
- Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen (PHASE4)
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation (NA)
- Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation (PHASE4)
- Sirolimus Conversions in African-American Renal Transplant Recipients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tacrolimus with steroids minimization CI brief — competitive landscape report
- Tacrolimus with steroids minimization updates RSS · CI watch RSS
- Armando Torres Ramírez portfolio CI